Skip to main content
Immunodiagnostics Market Analysis, Size, and Forecast 2026-2030: North America (US, Canada, and Mexico), Europe (Germany, France, and UK), Asia (China, Japan, and India), South America (Brazil, Argentina, and Colombia), Middle East and Africa (Saudi Arabia, Turkey, and UAE), Rest of World (ROW)

Immunodiagnostics Market Analysis, Size, and Forecast 2026-2030:
North America (US, Canada, and Mexico), Europe (Germany, France, and UK), Asia (China, Japan, and India), South America (Brazil, Argentina, and Colombia), Middle East and Africa (Saudi Arabia, Turkey, and UAE), Rest of World (ROW)

Published: Oct 2026 315 Pages SKU: IRTNTR44345

Market Overview at a Glance

$41.01 B
Market Opportunity
14.7%
CAGR 2025 - 2030
34.1%
North America Growth
$27.88 B
Reagents and consumables segment 2024

Immunodiagnostics Market Size 2026-2030

The immunodiagnostics market size is valued to increase by USD 41.01 billion, at a CAGR of 14.7% from 2025 to 2030. Rising global prevalence of chronic and infectious disease pathology will drive the immunodiagnostics market.

Major Market Trends & Insights

  • North America dominated the market and accounted for a 34.1% growth during the forecast period.
  • By Product - Reagents and consumables segment was valued at USD 27.88 billion in 2024
  • By Application - Oncology and endocrinology segment accounted for the largest market revenue share in 2024

Market Size & Forecast

  • Market Opportunities: USD 58.05 billion
  • Market Future Opportunities: USD 41.01 billion
  • CAGR from 2025 to 2030 : 14.7%

Market Summary

  • The Immunodiagnostics sector operates as a critical diagnostic infrastructure supporting high-volume clinical pathology and complex disease management. As healthcare networks prioritize early intervention, the deployment of high-throughput automated analyzers has become an operational necessity for managing escalating daily test volumes.
  • For example, large-scale reference laboratories implementing fully automated immunoassay tracks have reduced manual pipetting errors by 22%, significantly improving diagnostic turnaround times for acute cardiac and infectious disease markers. This transformation is primarily driven by the escalating clinical requirement for longitudinal biological monitoring among aging populations with complex multi-organ chronic conditions.
  • Consequently, healthcare facilities are rapidly expanding their operational capacity to process high-throughput serological diagnostic screening panels. Conversely, the industry faces severe structural limitations due to increasingly stringent regulatory compliance mandates, which extend product validation lifecycles and increase capital expenditure.
  • Overcoming these regulatory bottlenecks requires robust centralized quality control oversight and extensive multi-site clinical trial validations to ensure absolute assay precision and reproducibility.

What will be the Size of the Immunodiagnostics Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Get Free Sample

How is the Immunodiagnostics Market Segmented?

The immunodiagnostics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2026-2030, as well as historical data from 2020-2024 for the following segments.

  • Product
    • Reagents and consumables
    • Immunodiagnostic systems
  • Application
    • Oncology and endocrinology
    • Hepatitis and retrovirus
    • Infectious disease
    • GI stool
    • Others
  • End-user
    • Diagnostic laboratories
    • Hospitals and clinics
    • Academic and research institutes
    • Others
  • Geography
    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • The Netherlands
    • Asia
      • China
      • Japan
      • India
      • South Korea
      • Indonesia
      • Thailand
    • Rest of World (ROW)

By Product Insights

The reagents and consumables segment is estimated to witness significant growth during the forecast period.

The reagents and consumables category within the Immunodiagnostics landscape functions as the high-margin recurring revenue engine for clinical laboratories. Facilities mandate continuous procurement of specialized autoimmune disease immunoassay kits and fluorogenic detection substrates to execute high-volume serological evaluations.

Transitioning to advanced chemiluminescence immunoassay platforms requires proprietary assay buffers and recombinant antigen formulations, creating a strict annuity model. By integrating standardized microplates into automated sample processing tracks, diagnostic centers have successfully reduced pre-analytical specimen handling errors by 18%.

This shift ensures continuous operational uptime during peak infectious disease screening cycles. Relying on highly calibrated monoclonal antibody reagents minimizes false-positive rates, directly optimizing testing specificity for complex specific antigen-antibody reactions.

Consequently, the reliance on premium diagnostic consumables remains paramount for maintaining clinical accuracy and operational profitability.

Get Free Sample

The Reagents and consumables segment was valued at USD 27.88 billion in 2024 and showed a gradual increase during the forecast period.

Get Free Sample

Regional Analysis

North America is estimated to contribute 34.1% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

See How Immunodiagnostics Market Demand is Rising in North America Get Free Sample

The geographic distribution of the Immunodiagnostics landscape reveals distinct operational priorities, particularly between North America and APAC.

North American healthcare networks maintain a 34% higher adoption rate of fully automated chemiluminescent immunoassay analytical workstations compared to European counterparts, driven by stringent mandates for high-volume precision oncology and infectious disease screening.

This regional advantage allows US-based laboratories to achieve a 20% reduction in equipment downtime through the integration of predictive maintenance algorithms.

Conversely, the APAC region demonstrates rapid clinical modernization, expanding the deployment of point-of-care testing units by 28% across rural and semi-urban health centers.

While mature markets heavily utilize sophisticated enzyme-linked immunosorbent assays for complex applications like early neurodegenerative screening, emerging Asian economies prioritize scalable, cost-effective infectious disease diagnostic infrastructure to manage rising patient volumes efficiently.

Market Dynamics

Our researchers analyzed the data with 2025 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

  • The structural progression of the Immunodiagnostics environment is heavily dependent on optimizing laboratory throughput and enhancing early disease detection capabilities. As modern healthcare facilities face unprecedented daily sample volumes, administrators are aggressively transitioning toward automated chemiluminescent immunoassay analytical workstations.
  • This strategic infrastructure upgrade minimizes manual intervention and allows clinical reference centers to process specimens 35% faster than facilities relying on decoupled legacy equipment. Furthermore, the integration of predictive machine learning laboratory algorithms empowers pathologists to auto-verify normal results and anticipate reagent shortages, ensuring uninterrupted supply chain continuity during seasonal viral outbreaks.
  • Concurrently, there is a pronounced clinical migration toward decentralized microfluidic point-of-care testing, which brings sophisticated diagnostic capabilities directly to urgent care clinics and remote outpatient settings. This shift fundamentally alters clinical workflows by enabling physicians to execute high-throughput serological diagnostic screening panels during a single patient visit, drastically accelerating therapeutic decision-making.
  • In specialized medical disciplines, the demand for targeted biomarker profiling is surging, driving the commercial adoption of specialized autoimmune disease immunoassay kits capable of quantifying ultra-low antibody concentrations.
  • By standardizing these advanced testing protocols across widespread hospital networks, healthcare providers consistently achieve superior diagnostic precision, reduce the frequency of costly repeat testing, and establish highly efficient, scalable diagnostic operations capable of supporting global public health initiatives.

What are the key market drivers leading to the rise in the adoption of Immunodiagnostics Industry?

  • The escalating prevalence of chronic medical conditions and infectious disease pathologies functions as a primary catalyst expanding the demand for advanced serological testing.

  • The urgent operational mandate to mitigate critical medical technician shortages serves as a primary catalyst expanding the Immunodiagnostics sector. Pathology departments face overwhelming daily workloads, forcing a rapid transition toward total laboratory automation to sustain clinical throughput.
  • By integrating smart robotic tracks, hospitals have lowered manual processing errors by 22% and improved diagnostic turnaround times by 30% for emergency biomarker assessments.
  • To maintain this continuous operational uptime, modern immunoassay analyzers utilize intelligent reagent inventory tracking software that autonomously prevents supply chain disruptions. Furthermore, the development of highly specific monoclonal antibody reagents ensures exceptional analytical precision across high-volume testing environments.
  • This structural modernization empowers healthcare facilities to process thousands of samples efficiently, directly satisfying the escalating global demand for complex infectious disease and chronic illness serological screening.

What are the market trends shaping the Immunodiagnostics Industry?

  • The structural transition toward decentralized point-of-care immunoassay testing platforms represents a prominent technological trend transforming clinical diagnostic workflows.

  • The accelerated commercialization of blood-based neuro-biomarkers represents a transformative trend fundamentally altering the Immunodiagnostics landscape. Historically reliant on invasive cerebrospinal fluid draws, neurologists now leverage high-sensitivity plasma assays to identify pre-symptomatic neurodegenerative pathologies. This methodological shift improves patient screening compliance by 40% and reduces preliminary diagnostic costs by 25%.
  • This evolution is strongly supported by ongoing microfluidic immunoassay innovation, which enables the rapid execution of multi-analyte disease panels directly at the point of care. Furthermore, manufacturers are actively expanding the automated diagnostic menu on existing platforms, ensuring seamless clinical workflow integration across decentralized health centers.
  • By consolidating these advanced testing capabilities, outpatient clinics can deliver definitive, quantitative results in minutes, empowering physicians to initiate targeted therapeutic interventions immediately and optimizing overall healthcare delivery efficiency.

What challenges does the Immunodiagnostics Industry face during its growth?

  • Stringent regulatory frameworks and evolving compliance mandates for in vitro diagnostic devices present substantial operational challenges for assay manufacturers.

  • Persistent analytical constraints driven by complex matrix interference remain a severe structural limitation within the Immunodiagnostics environment. When testing biological patient samples, endogenous substances such as heterophilic antibodies frequently disrupt specific antigen-antibody reactions, leading to false-positive or false-negative diagnostic readings.
  • This chemical cross-reactivity forces clinical laboratories to execute costly secondary validation protocols, inadvertently increasing operational overhead by 15% and delaying critical patient care decisions. Furthermore, the absence of universal standardization across proprietary diagnostic platforms introduces a 12% variability rate in immunoassay analytical interpretation between competing analyzer systems.
  • Navigating these technical discrepancies demands extensive centralized quality control oversight and prolonged reagent engineering cycles, placing heavy financial burdens on diagnostic manufacturers and restricting the rapid commercial expansion of novel high-sensitivity biomarker panels.

Exclusive Technavio Analysis on Customer Landscape

The immunodiagnostics market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the immunodiagnostics market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Customer Landscape of Immunodiagnostics Industry

Competitive Landscape

Companies are implementing various strategies, such as strategic alliances, immunodiagnostics market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

Abbott Laboratories - Delivers advanced immunodiagnostic systems, including high-throughput analyzers and comprehensive immunoassay testing menus targeting infectious diseases, cardiac biomarkers, and oncology applications for optimized performance.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

  • Abbott Laboratories
  • Abcam plc
  • Agilent Technologies Inc.
  • Becton Dickinson and Co.
  • Bio Rad Laboratories Inc.
  • Bio Techne Corp.
  • Danaher Corp.
  • DiaSorin SpA
  • Eurofins Scientific SE
  • F. Hoffmann La Roche Ltd.
  • Grifols SA
  • Merck KGaA
  • Promega Corp.
  • QIAGEN N.V.
  • QuidelOrtho Corp.
  • Randox Laboratories Ltd.
  • Revvity Inc.
  • Siemens Healthineers AG
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Immunodiagnostics market

  • In the Life Sciences Tools and Services industry, the transition toward total laboratory automation systems increased processing capacities by 40%, directly impacting Immunodiagnostics demand by requiring highly adaptable reagent inventory tracking software.
  • The enforcement of the In Vitro Diagnostic Regulation across European health networks mandated a 100% compliance rate for clinical workflow integration, compelling manufacturers to re-validate complex matrix interference limits for all serological assays.
  • Widespread implementation of decentralized microfluidic point-of-care testing infrastructure reduced average patient wait times by 25%, establishing new baseline performance standards for multi-analyte disease panels in emergency care centers.
  • Advances in predictive machine learning laboratory algorithms improved diagnostic analytical accuracy by 15%, driving the rapid adoption of automated diagnostic menu expansions tailored for early neurodegenerative screening protocols.

Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Immunodiagnostics Market insights. See full methodology.

Market Scope
Page number 315
Base year 2025
Historic period 2020-2024
Forecast period 2026-2030
Growth momentum & CAGR Accelerate at a CAGR of 14.7%
Market growth 2026-2030 USD 41008.6 million
Market structure Fragmented
YoY growth 2025-2026(%) 13.2%
Key countries US, Canada, Mexico, Germany, France, UK, Italy, Spain, The Netherlands, China, Japan, India, South Korea, Indonesia, Thailand, Brazil, Saudi Arabia, Turkey, UAE, Argentina, South Africa, Colombia and Israel
Competitive landscape Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Request Free Sample

Research Analyst Overview

  • The continuous evolution of the Immunodiagnostics sector mandates a strategic reassessment of capital equipment investments and compliance frameworks at the boardroom level. Hospital administrators increasingly prioritize the procurement of multiplex microfluidic biochips to consolidate disparate testing menus onto unified, high-efficiency platforms.
  • This operational shift directly addresses critical labor shortages, enabling modern laboratories to achieve a 30% reduction in sample processing time compared to traditional singular diagnostic runs. Furthermore, the clinical integration of single molecule array technologies empowers physicians to detect ultra-low biomarker concentrations, fundamentally transforming early intervention strategies.
  • To support these sensitive diagnostic requirements, manufacturers continuously refine recombinant antigen formulations designed to actively suppress complex matrix interference within patient samples. This rigorous technological enhancement ensures that life-saving evaluations, such as high-sensitivity cardiac troponin measurements, deliver definitive results without analytical variability.
  • Ultimately, the adoption of these sophisticated assay architectures allows healthcare executives to streamline regulatory reporting, minimize diagnostic errors, and establish resilient laboratory infrastructures capable of executing high-precision serological evaluations under immense operational pressure.

What are the Key Data Covered in this Immunodiagnostics Market Research and Growth Report?

  • What is the expected growth of the Immunodiagnostics Market between 2026 and 2030?

    • USD 41.01 billion, at a CAGR of 14.7%

  • What segmentation does the market report cover?

    • The report is segmented by Product (Reagents and consumables, and Immunodiagnostic systems), Application (Oncology and endocrinology, Hepatitis and retrovirus, Infectious disease, GI stool, and Others), End-user (Diagnostic laboratories, Hospitals and clinics, Academic and research institutes, and Others) and Geography (North America, Europe, Asia, Rest of World (ROW))

  • Which regions are analyzed in the report?

    • North America, Europe, Asia and Rest of World (ROW)

  • What are the key growth drivers and market challenges?

    • Rising global prevalence of chronic and infectious disease pathology, Strict regulatory frameworks and evolving in vitro diagnostic compliance requirements

  • Who are the major players in the Immunodiagnostics Market?

    • Abbott Laboratories, Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., Danaher Corp., DiaSorin SpA, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Grifols SA, Merck KGaA, Promega Corp., QIAGEN N.V., QuidelOrtho Corp., Randox Laboratories Ltd., Revvity Inc., Siemens Healthineers AG, Sysmex Corp. and Thermo Fisher Scientific Inc.

Market Research Insights

  • The Immunodiagnostics landscape is undergoing a structural evolution driven by high-efficiency processing mandates and advanced biomarker discovery. Modern clinical reference laboratories rapidly integrate intelligent diagnostic software, improving immunoassay analytical interpretation accuracy by 18% compared to legacy manual reading methods. This shift allows pathology networks to process complex biological patient samples with superior analytical specificity, reducing false-positive rates by 14%.
  • Furthermore, the expanding utilization of precision oncology biomarkers directly enables oncologists to tailor targeted therapies faster, cutting patient diagnostic delays by 25%. By optimizing these automated workflows, healthcare administrators successfully mitigate skilled labor shortages while maintaining rigorous diagnostic standards across high-volume outpatient care centers.

We can help! Our analysts can customize this immunodiagnostics market research report to meet your requirements.

Get in touch

1. Executive Summary

1.1 Market overview

Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2. Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

2.2 Criticality of inputs and Factors of differentiation

Chart on Overview on criticality of inputs and factors of differentiation

2.3 Factors of disruption

Chart on Overview on factors of disruption

2.4 Impact of drivers and challenges

Chart on Impact of drivers and challenges in 2025 and 2030

3. Market Landscape

3.1 Market ecosystem

Chart on Parent Market
Data Table on - Parent Market

3.2 Market characteristics

Chart on Market characteristics analysis

3.3 Value chain analysis

Chart on Value chain analysis

4. Market Sizing

4.1 Market definition

Data Table on Offerings of companies included in the market definition

4.2 Market segment analysis

Market segments

4.3 Market size 2025

4.4 Market outlook: Forecast for 2025-2030

Chart on Global - Market size and forecast 2025-2030 ($ million)
Data Table on Global - Market size and forecast 2025-2030 ($ million)
Chart on Global Market: Year-over-year growth 2025-2030 (%)
Data Table on Global Market: Year-over-year growth 2025-2030 (%)

5. Historic Market Size

5.1 Global Immunodiagnostics Market 2020 - 2024

Historic Market Size - Data Table on Global Immunodiagnostics Market 2020 - 2024 ($ million)

5.2 Product segment analysis 2020 - 2024

Historic Market Size - Product Segment 2020 - 2024 ($ million)

5.3 Application segment analysis 2020 - 2024

Historic Market Size - Application Segment 2020 - 2024 ($ million)

5.4 End-user segment analysis 2020 - 2024

Historic Market Size - End-user Segment 2020 - 2024 ($ million)

5.5 Geography segment analysis 2020 - 2024

Historic Market Size - Geography Segment 2020 - 2024 ($ million)

5.6 Country segment analysis 2020 - 2024

Historic Market Size - Country Segment 2020 - 2024 ($ million)

6. Qualitative Analysis

6.1 Impact of AI on global immunodiagnostics market

6.2 Impact of geopolitical conflicts on global immunodiagnostics market

7. Five Forces Analysis

7.1 Five forces summary

Five forces analysis - Comparison between 2025 and 2030

7.2 Bargaining power of buyers

Bargaining power of buyers - Impact of key factors 2025 and 2030

7.3 Bargaining power of suppliers

Bargaining power of suppliers - Impact of key factors in 2025 and 2030

7.4 Threat of new entrants

Threat of new entrants - Impact of key factors in 2025 and 2030

7.5 Threat of substitutes

Threat of substitutes - Impact of key factors in 2025 and 2030

7.6 Threat of rivalry

Threat of rivalry - Impact of key factors in 2025 and 2030

7.7 Market condition

Chart on Market condition - Five forces 2025 and 2030

8. Market Segmentation by Product

8.1 Market segments

Chart on Product - Market share 2025-2030 (%)
Data Table on Product - Market share 2025-2030 (%)

8.2 Comparison by Product

Chart on Comparison by Product
Data Table on Comparison by Product

8.3 Reagents and consumables - Market size and forecast 2025-2030

Chart on Reagents and consumables - Market size and forecast 2025-2030 ($ million)
Data Table on Reagents and consumables - Market size and forecast 2025-2030 ($ million)
Chart on Reagents and consumables - Year-over-year growth 2025-2030 (%)
Data Table on Reagents and consumables - Year-over-year growth 2025-2030 (%)

8.4 Immunodiagnostic systems - Market size and forecast 2025-2030

Chart on Immunodiagnostic systems - Market size and forecast 2025-2030 ($ million)
Data Table on Immunodiagnostic systems - Market size and forecast 2025-2030 ($ million)
Chart on Immunodiagnostic systems - Year-over-year growth 2025-2030 (%)
Data Table on Immunodiagnostic systems - Year-over-year growth 2025-2030 (%)

8.5 Market opportunity by Product

Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)

9. Market Segmentation by Application

9.1 Market segments

Chart on Application - Market share 2025-2030 (%)
Data Table on Application - Market share 2025-2030 (%)

9.2 Comparison by Application

Chart on Comparison by Application
Data Table on Comparison by Application

9.3 Oncology and endocrinology - Market size and forecast 2025-2030

Chart on Oncology and endocrinology - Market size and forecast 2025-2030 ($ million)
Data Table on Oncology and endocrinology - Market size and forecast 2025-2030 ($ million)
Chart on Oncology and endocrinology - Year-over-year growth 2025-2030 (%)
Data Table on Oncology and endocrinology - Year-over-year growth 2025-2030 (%)

9.4 Hepatitis and retrovirus - Market size and forecast 2025-2030

Chart on Hepatitis and retrovirus - Market size and forecast 2025-2030 ($ million)
Data Table on Hepatitis and retrovirus - Market size and forecast 2025-2030 ($ million)
Chart on Hepatitis and retrovirus - Year-over-year growth 2025-2030 (%)
Data Table on Hepatitis and retrovirus - Year-over-year growth 2025-2030 (%)

9.5 Infectious disease - Market size and forecast 2025-2030

Chart on Infectious disease - Market size and forecast 2025-2030 ($ million)
Data Table on Infectious disease - Market size and forecast 2025-2030 ($ million)
Chart on Infectious disease - Year-over-year growth 2025-2030 (%)
Data Table on Infectious disease - Year-over-year growth 2025-2030 (%)

9.6 GI stool - Market size and forecast 2025-2030

Chart on GI stool - Market size and forecast 2025-2030 ($ million)
Data Table on GI stool - Market size and forecast 2025-2030 ($ million)
Chart on GI stool - Year-over-year growth 2025-2030 (%)
Data Table on GI stool - Year-over-year growth 2025-2030 (%)

9.7 Others - Market size and forecast 2025-2030

Chart on Others - Market size and forecast 2025-2030 ($ million)
Data Table on Others - Market size and forecast 2025-2030 ($ million)
Chart on Others - Year-over-year growth 2025-2030 (%)
Data Table on Others - Year-over-year growth 2025-2030 (%)

9.8 Market opportunity by Application

Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)

10. Market Segmentation by End-user

10.1 Market segments

Chart on End-user - Market share 2025-2030 (%)
Data Table on End-user - Market share 2025-2030 (%)

10.2 Comparison by End-user

Chart on Comparison by End-user
Data Table on Comparison by End-user

10.3 Diagnostic laboratories - Market size and forecast 2025-2030

Chart on Diagnostic laboratories - Market size and forecast 2025-2030 ($ million)
Data Table on Diagnostic laboratories - Market size and forecast 2025-2030 ($ million)
Chart on Diagnostic laboratories - Year-over-year growth 2025-2030 (%)
Data Table on Diagnostic laboratories - Year-over-year growth 2025-2030 (%)

10.4 Hospitals and clinics - Market size and forecast 2025-2030

Chart on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
Data Table on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
Chart on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
Data Table on Hospitals and clinics - Year-over-year growth 2025-2030 (%)

10.5 Academic and research institutes - Market size and forecast 2025-2030

Chart on Academic and research institutes - Market size and forecast 2025-2030 ($ million)
Data Table on Academic and research institutes - Market size and forecast 2025-2030 ($ million)
Chart on Academic and research institutes - Year-over-year growth 2025-2030 (%)
Data Table on Academic and research institutes - Year-over-year growth 2025-2030 (%)

10.6 Others - Market size and forecast 2025-2030

Chart on Others - Market size and forecast 2025-2030 ($ million)
Data Table on Others - Market size and forecast 2025-2030 ($ million)
Chart on Others - Year-over-year growth 2025-2030 (%)
Data Table on Others - Year-over-year growth 2025-2030 (%)

10.7 Market opportunity by End-user

Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)

11. Customer Landscape

11.1 Customer landscape overview

Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12. Geographic Landscape

12.1 Geographic segmentation

Chart on Market share by geography 2025-2030 (%)
Data Table on Market share by geography 2025-2030 (%)

12.2 Geographic comparison

Chart on Geographic comparison
Data Table on Geographic comparison

12.3 North America - Market size and forecast 2025-2030

Chart on North America - Market size and forecast 2025-2030 ($ million)
Data Table on North America - Market size and forecast 2025-2030 ($ million)
Chart on North America - Year-over-year growth 2025-2030 (%)
Data Table on North America - Year-over-year growth 2025-2030 (%)
Chart on Regional Comparison - North America
Data Table on Regional Comparison - North America

12.3.1 US - Market size and forecast 2025-2030

Chart on US - Market size and forecast 2025-2030 ($ million)
Data Table on US - Market size and forecast 2025-2030 ($ million)
Chart on US - Year-over-year growth 2025-2030 (%)
Data Table on US - Year-over-year growth 2025-2030 (%)

12.3.2 Canada - Market size and forecast 2025-2030

Chart on Canada - Market size and forecast 2025-2030 ($ million)
Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Chart on Canada - Year-over-year growth 2025-2030 (%)
Data Table on Canada - Year-over-year growth 2025-2030 (%)

12.3.3 Mexico - Market size and forecast 2025-2030

Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Chart on Mexico - Year-over-year growth 2025-2030 (%)
Data Table on Mexico - Year-over-year growth 2025-2030 (%)

12.4 Europe - Market size and forecast 2025-2030

Chart on Europe - Market size and forecast 2025-2030 ($ million)
Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Chart on Europe - Year-over-year growth 2025-2030 (%)
Data Table on Europe - Year-over-year growth 2025-2030 (%)
Chart on Regional Comparison - Europe
Data Table on Regional Comparison - Europe

12.4.1 Germany - Market size and forecast 2025-2030

Chart on Germany - Market size and forecast 2025-2030 ($ million)
Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Chart on Germany - Year-over-year growth 2025-2030 (%)
Data Table on Germany - Year-over-year growth 2025-2030 (%)

12.4.2 France - Market size and forecast 2025-2030

Chart on France - Market size and forecast 2025-2030 ($ million)
Data Table on France - Market size and forecast 2025-2030 ($ million)
Chart on France - Year-over-year growth 2025-2030 (%)
Data Table on France - Year-over-year growth 2025-2030 (%)

12.4.3 UK - Market size and forecast 2025-2030

Chart on UK - Market size and forecast 2025-2030 ($ million)
Data Table on UK - Market size and forecast 2025-2030 ($ million)
Chart on UK - Year-over-year growth 2025-2030 (%)
Data Table on UK - Year-over-year growth 2025-2030 (%)

12.4.4 Italy - Market size and forecast 2025-2030

Chart on Italy - Market size and forecast 2025-2030 ($ million)
Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Chart on Italy - Year-over-year growth 2025-2030 (%)
Data Table on Italy - Year-over-year growth 2025-2030 (%)

12.4.5 Spain - Market size and forecast 2025-2030

Chart on Spain - Market size and forecast 2025-2030 ($ million)
Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Chart on Spain - Year-over-year growth 2025-2030 (%)
Data Table on Spain - Year-over-year growth 2025-2030 (%)

12.4.6 The Netherlands - Market size and forecast 2025-2030

Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)

12.5 Asia - Market size and forecast 2025-2030

Chart on Asia - Market size and forecast 2025-2030 ($ million)
Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Chart on Asia - Year-over-year growth 2025-2030 (%)
Data Table on Asia - Year-over-year growth 2025-2030 (%)
Chart on Regional Comparison - Asia
Data Table on Regional Comparison - Asia

12.5.1 China - Market size and forecast 2025-2030

Chart on China - Market size and forecast 2025-2030 ($ million)
Data Table on China - Market size and forecast 2025-2030 ($ million)
Chart on China - Year-over-year growth 2025-2030 (%)
Data Table on China - Year-over-year growth 2025-2030 (%)

12.5.2 Japan - Market size and forecast 2025-2030

Chart on Japan - Market size and forecast 2025-2030 ($ million)
Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Chart on Japan - Year-over-year growth 2025-2030 (%)
Data Table on Japan - Year-over-year growth 2025-2030 (%)

12.5.3 India - Market size and forecast 2025-2030

Chart on India - Market size and forecast 2025-2030 ($ million)
Data Table on India - Market size and forecast 2025-2030 ($ million)
Chart on India - Year-over-year growth 2025-2030 (%)
Data Table on India - Year-over-year growth 2025-2030 (%)

12.5.4 South Korea - Market size and forecast 2025-2030

Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Chart on South Korea - Year-over-year growth 2025-2030 (%)
Data Table on South Korea - Year-over-year growth 2025-2030 (%)

12.5.5 Indonesia - Market size and forecast 2025-2030

Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Data Table on Indonesia - Year-over-year growth 2025-2030 (%)

12.5.6 Thailand - Market size and forecast 2025-2030

Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Chart on Thailand - Year-over-year growth 2025-2030 (%)
Data Table on Thailand - Year-over-year growth 2025-2030 (%)

12.6 Rest of World (ROW) - Market size and forecast 2025-2030

Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Chart on Regional Comparison - Rest of World (ROW)
Data Table on Regional Comparison - Rest of World (ROW)

12.6.1 Brazil - Market size and forecast 2025-2030

Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Chart on Brazil - Year-over-year growth 2025-2030 (%)
Data Table on Brazil - Year-over-year growth 2025-2030 (%)

12.6.2 Saudi Arabia - Market size and forecast 2025-2030

Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)

12.6.3 Turkey - Market size and forecast 2025-2030

Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Chart on Turkey - Year-over-year growth 2025-2030 (%)
Data Table on Turkey - Year-over-year growth 2025-2030 (%)

12.6.4 UAE - Market size and forecast 2025-2030

Chart on UAE - Market size and forecast 2025-2030 ($ million)
Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Chart on UAE - Year-over-year growth 2025-2030 (%)
Data Table on UAE - Year-over-year growth 2025-2030 (%)

12.6.5 Argentina - Market size and forecast 2025-2030

Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Chart on Argentina - Year-over-year growth 2025-2030 (%)
Data Table on Argentina - Year-over-year growth 2025-2030 (%)

12.6.6 South Africa - Market size and forecast 2025-2030

Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Chart on South Africa - Year-over-year growth 2025-2030 (%)
Data Table on South Africa - Year-over-year growth 2025-2030 (%)

12.6.7 Colombia - Market size and forecast 2025-2030

Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Chart on Colombia - Year-over-year growth 2025-2030 (%)
Data Table on Colombia - Year-over-year growth 2025-2030 (%)

12.6.8 Israel - Market size and forecast 2025-2030

Chart on Israel - Market size and forecast 2025-2030 ($ million)
Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Chart on Israel - Year-over-year growth 2025-2030 (%)
Data Table on Israel - Year-over-year growth 2025-2030 (%)

12.7 Market opportunity by geography

Market opportunity by geography ($ million)
Data Tables on Market opportunity by geography ($ million)

13. Drivers, Challenges, and Opportunity

13.1 Market drivers

Rising global prevalence of chronic and infectious disease pathology
Accelerating demand for high throughput laboratory automation systems
Expanding clinical integration of high sensitivity cardiac biomarkers

13.2 Market challenges

Strict regulatory frameworks and evolving in vitro diagnostic compliance requirements
Reimbursement cutbacks and economic pressures on clinical laboratory operations
Technical matrix interference and assay standardization deficits across platforms

13.3 Impact of drivers and challenges

Impact of drivers and challenges in 2025 and 2030

13.4 Market opportunities

Shift toward point of care decentralized immunoassay testing platforms
Integration of AI in immunoassay analytical interpretation
Commercialization of novel biomarkers for early neurodegenerative screening

14. Competitive Landscape

14.1 Overview

14.2

Overview on criticality of inputs and factors of differentiation

14.3 Landscape disruption

Overview on factors of disruption

14.4 Industry risks

Impact of key risks on business

15. Competitive Analysis

15.1 Companies profiled

Companies covered

15.2 Company ranking index

15.3 Market positioning of companies

Matrix on companies position and classification

15.4 Abbott Laboratories

Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
SWOT

15.5 Agilent Technologies Inc.

Agilent Technologies Inc. - Overview
Agilent Technologies Inc. - Business segments
Agilent Technologies Inc. - Key news
Agilent Technologies Inc. - Key offerings
Agilent Technologies Inc. - Segment focus
SWOT

15.6 Becton Dickinson and Co.

Becton Dickinson and Co. - Overview
Becton Dickinson and Co. - Business segments
Becton Dickinson and Co. - Key news
Becton Dickinson and Co. - Key offerings
Becton Dickinson and Co. - Segment focus
SWOT

15.7 Bio Rad Laboratories Inc.

Bio Rad Laboratories Inc. - Overview
Bio Rad Laboratories Inc. - Business segments
Bio Rad Laboratories Inc. - Key news
Bio Rad Laboratories Inc. - Key offerings
Bio Rad Laboratories Inc. - Segment focus
SWOT

15.8 Bio Techne Corp.

Bio Techne Corp. - Overview
Bio Techne Corp. - Business segments
Bio Techne Corp. - Key news
Bio Techne Corp. - Key offerings
Bio Techne Corp. - Segment focus
SWOT

15.9 Danaher Corp.

Danaher Corp. - Overview
Danaher Corp. - Business segments
Danaher Corp. - Key news
Danaher Corp. - Key offerings
Danaher Corp. - Segment focus
SWOT

15.10 DiaSorin SpA

DiaSorin SpA - Overview
DiaSorin SpA - Business segments
DiaSorin SpA - Key news
DiaSorin SpA - Key offerings
DiaSorin SpA - Segment focus
SWOT

15.11 Eurofins Scientific SE

Eurofins Scientific SE - Overview
Eurofins Scientific SE - Business segments
Eurofins Scientific SE - Key offerings
Eurofins Scientific SE - Segment focus
SWOT

15.12 F. Hoffmann La Roche Ltd.

F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT

15.13 Merck KGaA

Merck KGaA - Overview
Merck KGaA - Business segments
Merck KGaA - Key news
Merck KGaA - Key offerings
Merck KGaA - Segment focus
SWOT

15.14 QIAGEN N.V.

QIAGEN N.V. - Overview
QIAGEN N.V. - Product / Service
QIAGEN N.V. - Key offerings
SWOT

15.15 QuidelOrtho Corp.

QuidelOrtho Corp. - Overview
QuidelOrtho Corp. - Business segments
QuidelOrtho Corp. - Key offerings
QuidelOrtho Corp. - Segment focus
SWOT

15.16 Revvity Inc.

Revvity Inc. - Overview
Revvity Inc. - Business segments
Revvity Inc. - Key offerings
Revvity Inc. - Segment focus
SWOT

15.17 Siemens Healthineers AG

Siemens Healthineers AG - Overview
Siemens Healthineers AG - Business segments
Siemens Healthineers AG - Key offerings
Siemens Healthineers AG - Segment focus
SWOT

15.18 Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key news
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Segment focus
SWOT

16. Appendix

16.1 Scope of the report

Market definition
Objectives
Notes and caveats

16.2 Inclusions and exclusions checklist

Inclusions checklist
Exclusions checklist

16.3 Currency conversion rates for US$

16.4 Research methodology

16.5 Data procurement

Information sources

16.6 Data validation

16.7 Validation techniques employed for market sizing

16.8 Data synthesis

16.9 360 degree market analysis

16.10 List of abbreviations

Research Methodology

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

Interested in this report?

Get your sample now to see our research methodology and insights!

Download Now

Frequently Asked Questions

Immunodiagnostics market growth will increase by USD 41008.6 million during 2026-2030.

The Immunodiagnostics market is expected to grow at a CAGR of 14.7% during 2026-2030.

Immunodiagnostics market is segmented by Product (Reagents and consumables, Immunodiagnostic systems) Application (Oncology and endocrinology, Hepatitis and retrovirus, Infectious disease, GI stool, Others) End-user (Diagnostic laboratories, Hospitals and clinics, Academic and research institutes, Others)

Abbott Laboratories, Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., Danaher Corp., DiaSorin SpA, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Grifols SA, Merck KGaA, Promega Corp., QIAGEN N.V., QuidelOrtho Corp., Randox Laboratories Ltd., Revvity Inc., Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc. are a few of the key vendors in the Immunodiagnostics market.

North America will register the highest growth rate of 34.1% among the other regions. Therefore, the Immunodiagnostics market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

US, Canada, Mexico, Germany, France, UK, Italy, Spain, The Netherlands, China, Japan, India, South Korea, Indonesia, Thailand, Brazil, Saudi Arabia, Turkey, UAE, Argentina, South Africa, Colombia, Israel

  • Rising global prevalence of chronic and infectious disease pathology is the driving factor this market.

The Immunodiagnostics market vendors should focus on grabbing business opportunities from the Product segment as it accounted for the largest market share in the base year.
RIA - Research AI Assistant
Ask RIA